• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines N-alkylpyrrolidines

Introduction to (R)-Tert-Butyl 1-(Cyclohexylmethyl)pyrrolidin-3-ylcarbamate (CAS No. 876160-15-5)

(R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate (CAS No. 876160-15-5) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential applications in the development of novel therapeutic agents. The chiral center in the molecule, specifically the (R) configuration, plays a crucial role in its biological activity and pharmacological properties.

The chemical structure of (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate consists of a tert-butyl carbamate group attached to a pyrrolidine ring, which is further substituted with a cyclohexylmethyl moiety. The tert-butyl carbamate group is known for its ability to protect amino functionalities during synthetic manipulations, making this compound a valuable intermediate in the synthesis of complex molecules. The cyclohexylmethyl substituent adds steric bulk and hydrophobicity, which can influence the compound's interactions with biological targets.

Recent studies have highlighted the importance of chiral compounds in drug discovery and development. The enantiomeric purity of (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate is critical for its biological activity. Enantiomers can exhibit different pharmacological profiles, with one enantiomer being more active or having fewer side effects than the other. Therefore, the synthesis and purification of the desired enantiomer are essential steps in the development of effective drugs.

In the context of medicinal chemistry, (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate has been explored as a building block for the synthesis of various bioactive molecules. Its structural features make it suitable for conjugation with other functional groups, such as aromatic rings or heterocycles, to create compounds with enhanced biological activity. For instance, researchers have utilized this compound to develop inhibitors of specific enzymes involved in disease pathways, such as kinases and proteases.

The pharmacological properties of (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate have been investigated in several preclinical studies. These studies have demonstrated that the compound exhibits potent activity against various biological targets, including receptors and enzymes. For example, it has shown promising results as an inhibitor of protein-protein interactions, which are often implicated in diseases such as cancer and neurodegenerative disorders.

In addition to its potential therapeutic applications, (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate has also been studied for its use in chemical biology research. The compound can be used as a tool to probe the function of specific proteins or pathways in cells. By selectively modulating protein activity, researchers can gain insights into the mechanisms underlying various biological processes and diseases.

The synthesis of (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate typically involves several steps, including the formation of the pyrrolidine ring and the introduction of the tert-butyl carbamate and cyclohexylmethyl groups. Various synthetic strategies have been developed to achieve high enantiomeric purity and yield. One common approach involves asymmetric synthesis using chiral catalysts or auxiliaries to control the stereochemistry at the chiral center.

The stability and solubility properties of (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate are important considerations for its use in pharmaceutical applications. The tert-butyl carbamate group can be cleaved under acidic conditions to release the free amine, which may be necessary for certain biological assays or drug delivery systems. Additionally, the cyclohexylmethyl substituent can affect the compound's solubility in both organic solvents and aqueous media, influencing its formulation and administration.

In conclusion, (R)-Tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate (CAS No. 876160-15-5) is a versatile chiral compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and enantiomeric purity make it an attractive candidate for the development of novel therapeutic agents and research tools. Ongoing studies continue to explore its biological activity and applications, contributing to advancements in drug discovery and chemical biology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)